Insulin Aspart

YP

Yifan Pharmaceutical Co., Ltd

Manufacturer · Finished Dosage FormsChina

Basic Information

289

14

7

4.5(77)

Category

Biopharmaceutical Products

Subcategory & Sub-subcategory

Biosimilars / Insulin & Growth Factor Biosimilars

Trade Type

Sell

Product Name

Insulin Aspart

Details

Substance

Specifications

IUPAC Name: (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoy
EC Number:
Molecular Weight: 5832
Chemical Formula: C₂₅₆H₃₈₇N₆₅O₇₉S₆
CAS Number: 116094-23-6
Regulatory Status: Pharmaceutical-grade material (drug-manufacturing quality)
Certification Standard: ChP compliant
Application: Adjunct therapy for type 2 diabetes with inadequate glycemic control

Documents

CEP Certificate

ISO9001

ISO14001

ISO22000

FDA

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product